In prostate cancer, IHC analysis demonstrated significantly higher plectin staining in prostate cancer tissues and lymph node metastases when compared to patient-matched benign prostate tissue and cancer-free lymph node tissues, respectively [11]. This evidence concerns the gene PLEC and cancer.